Postoperative drainage fluid in patients with pancreatic ductal adenocarcinoma as a patient-specific in vitro model of the postoperative inflammatory and immunoregulatory microenvironment
Open Access
- 30 June 2026
- journal article
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 34 (2) , 166-186
Abstract
Background. Pancreatic ductal adenocarcinoma is characterized by an aggressive clinical course, early metastasis, low five-year survival rates, and limited efficacy of immunotherapy. A key biological feature of this disease is the formation of a pronounced immunosuppressive microenvironment, in which macrophages and other myeloid cells play a crucial role. Postoperative drainage fluid, collected from the tumor bed following surgical intervention, may reflect local processes of inflammation, repair, and immune regulation during the early postoperative period, serving as a patient-specific source of biologically active mediators.Purpose – to characterize the cytokine profile of postoperative drainage fluid in patients with pancreatic ductal adenocarcinoma and to evaluate its impact on macrophage phenotype and the functional activity of CD8+ T lymphocytes.Materials and Methods. The object of the study was postoperative drainage fluid collected from patients with histologically verified pancreatic ductal adenocarcinoma after radical surgical treatment. To evaluate the immunomodulatory properties of the drainage fluid, a model of macrophage differentiation from peripheral blood monocytes of healthy donors in the presence of drainage fluid samples was used. Immuno-phenotyping of the cells was performed by flow cytometry using CD163, CD206, CD80, and HLA-DR markers. The functional consequences of macrophage polarization were evaluated in a coculture system with activated CD8+ T-cells. Cytokine concentrations in the drainage fluid were determined by multiplex immunoassay.Results. Incubation of macrophages with postoperative drainage fluid was associated with a phenotypic shift toward an immunosuppressive profile: the expression of CD163 and CD206 increased, while the expression of CD80 and HLA-DR decreased. Macrophages preincubated with drainage fluid suppressed the activation of CD8+ T-cells and reduced the cytotoxic killing of tumor cells by approximately 60–65%. High concentrations of CSF1, CCL2, IL-10, TGF-, and GM-CSF were detected in the drainage fluid. Pharmacological inhibition of CSF1R and CCR2 partially attenuated immunosuppressive macrophage polarization, while CD40 activation partially restored antitumor immune responses.Conclusions. Postoperative drainage fluid in patients with pancreatic ductal adenocarcinoma is an informative source of local soluble mediators that characterize the postoperative inflammatory and immunoregulatory microenvironment of the tumor bed. Its use in experimental models allows for the investigation of the mechanisms underlying macrophage polarization and postoperative immunosuppression, while also providing a rationale for potential immunomodulatory therapy approaches within the perioperative window.Keywords
This publication has 22 references indexed in Scilit:
- Tumor-associated macrophages in cancer: from mechanisms to applicationMolecular Biomedicine, 2025
- Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapyClinical and Translational Medicine, 2024
- Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy responseNature Communications, 2024
- Prognostic impact of peritoneal washing cytology in patients with biliary tract cancerLangenbeck's Archives of Surgery, 2024
- Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1Science Immunology, 2023
- Macrophages at the interface of the co-evolving cancer ecosystemCell, 2023
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Intraoperative radiation therapy induces immune response activity after pancreatic surgeryBMC Cancer, 2021
- CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b studyThe Lancet Oncology, 2021
- The 2019 WHO classification of tumours of the digestive systemHistopathology, 2019